Wound closure device
View Patent ↗Biocompatible wound closure devices including an elongate body and a plug member are useful for wound repair. A wound closure device includes an elongate body defining a longitudinal axis and having a proximal end and a distal end, and a plug member having a tissue facing surface and including a first shaped section and a second shaped section, each of the first and second shaped sections having an abutment surface. The first and second shaped sections are movable about a hinge between a collapsed position in which the abutment surfaces extend away from the longitudinal axis of the elongate body and a deployed position in which the abutment surfaces abut and are substantially aligned with the longitudinal axis of the elongate body, the abutment surfaces controlling a deployed angle of the tissue facing surface of the plug member with respect to the elongate body.
1. A wound closure device comprising:
an elongate body defining a longitudinal axis and having a proximal end and a distal end;
a plug member having a tissue facing surface and including a first shaped section and a second shaped section, each of the first and second shaped sections having an abutment surface; and
a hinge connecting the tissue facing surface of the plug member to the elongate body, the first and second shaped sections being movable about the hinge between a collapsed position in which the abutment surfaces of the first and second shaped sections extend away from the longitudinal axis of the elongate body and a deployed position in which the abutment surfaces of the first and second shaped sections abut and are substantially aligned with the longitudinal axis of the elongate body, the abutment surfaces controlling a deployed angle of the tissue facing surface with respect to the elongate body.
2. The wound closure device according to claim 1 , wherein the tissue facing surface of the plug member further comprises at least one reactive group.
3. The wound closure device according to claim 2 , wherein the at least one reactive group of the tissue facing surface is selected from the group consisting of isocyanates, N-hydroxy succinimides, cyanoacrylates, aldehydes, genipin, trilysine, tetralysine, polylysines, diimides, diisocyanates, cyanamides, carbodiimides, dimethyl adipimidate, starches, and combinations thereof.
4. The wound closure device according to claim 1 , wherein the device comprises a polymer selected from the group consisting of nucleophilic polymers, electrophilic polymers, and combinations thereof.
5. The wound closure device according to claim 1 , wherein the elongate body, the plug member, or both, comprise a hydrogel.
6. The wound closure device according to claim 1 , wherein the plug member comprises a mesh on the tissue facing surface.
7. The wound closure device according to claim 1 , wherein the elongate body comprises a mesh.
8. The wound closure device according to claim 7 , wherein the mesh is bioabsorbable.
9. The wound closure device according to claim 1 , wherein the plug member includes a distal end having an anti-adhesive coating.
10. The wound closure device according to claim 1 , wherein the first and second shaped sections of the plug member are substantially identical.
11. The wound closure device according to claim 1 , wherein the plug member comprises at least one reactive group.
12. The wound closure device according to claim 11 , wherein the at least one reactive group is selected from the group consisting of isocyanates, N-hydroxy succinimides, cyanoacrylates, aldehydes, genipin, trilysine, tetralysine, polylysines, diimides, diisocyanates, cyanamides, carbodiimides, dimethyl adipimidate, starches, and combinations thereof.
13. The wound closure device according to claim 1 , wherein tissue facing surface of the plug member is substantially perpendicular to the longitudinal axis of the elongate body in the deployed position, and the abutments surfaces prevent the tissue facing surface from extending beyond the deployed angle of about 90°.